ARHGEF4 predicts poor prognosis and promotes cell invasion by influencing ERK1/2 and GSK-3α/β signaling in pancreatic cancerKeisuke Taniuchi, Toshiji Saibara|International Journal of Oncology|2018Cited by 11
Inhibitory effects of the combination of rapamycin with gemcitabine plus paclitaxel on the growth of pancreatic cancer tumorsYuri Jobu, Keisuke Taniuchi|Human Cell|2025Cited by 3